MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases
NCT05417282
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Cognitive Dysfunction, Cognitive Disorder
Interventions
DRUG:
MW151
Sponsor
ImmunoChem Therapeutics, LLC
Collaborators
[object Object]
[object Object]